Exact Mass: 505.16224320000003
Exact Mass Matches: 505.16224320000003
Found 280 metabolites which its exact mass value is equals to given mass value 505.16224320000003
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
alangiside
C25H31NO10 (505.19478660000004)
An organic heterotetracyclic compound that is an alkaloidal glycoside isolated from Alangium salviifolium.
N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-amine
Peonidin 3-(6'-acetyl-galactoside)
Peonidin 3-(6-acetyl-galactoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Peonidin 3-(6-acetyl-galactoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-(6-acetyl-galactoside) can be found in highbush blueberry and lowbush blueberry, which makes peonidin 3-(6-acetyl-galactoside) a potential biomarker for the consumption of these food products.
Peonidin 3-(6'-acetyl-glucoside)
Peonidin 3-(6-acetyl-glucoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Peonidin 3-(6-acetyl-glucoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-(6-acetyl-glucoside) can be found in common grape, grape wine, highbush blueberry, and lowbush blueberry, which makes peonidin 3-(6-acetyl-glucoside) a potential biomarker for the consumption of these food products.
Peonidin 3-(6-acetylglucoside)
10-(Methylthio)decyl glucosinolate
C18H35NO9S3 (505.14738600000004)
3-O-demethyl-2-O-methylisoalangiside
C25H31NO10 (505.19478660000004)
beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-tyrosyl]glucopyranoside
Glu Asp Gln Asp
Rocaglamide
Rocaglamide is an organic heterotricyclic compound that is 2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d]furan substituted by hydroxy groups at positions 1 and 8b, methoxy groups at positions 6 and 8, a 4-methoxyphenyl group at position 3a, a phenyl group at position 3 and a N,N-dimethylcarbamoyl group at position 1. Isolated from Aglaia odorata and Aglaia duperreana, it exhibits antineoplastic activity. It has a role as a metabolite, an antineoplastic agent and an antileishmanial agent. It is an organic heterotricyclic compound, a monomethoxybenzene and a monocarboxylic acid amide. Rocaglamide, also referred to as rocaglamide-A, is the eponymous member of a class of anti-cancer phytochemicals known as rocaglamides. Rocaglamides are secondary metabolites of the plant genus Aglaia, and extracts of the plant have traditionally been used as a form of insect repellant due to its natural insecticidal properties. Reports of Aglaia anti-tumor activity date back as far as 1973, and rocaglamide-A was first isolated in 1982 from the species A. elliptifolia. Rocaglamide and a number of its derivatives (e.g. [didesmethylrocaglamide]) are currently being studied for use as chemotherapeutic agents in the treatment of various leukemias, lymphomas, and carcinomas, as well as adjuvant therapy in the treatment of certain chemotherapy-resistant cancers. Rocaglamide is a natural product found in Aglaia rimosa, Aglaia elliptifolia, and other organisms with data available. An organic heterotricyclic compound that is 2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d]furan substituted by hydroxy groups at positions 1 and 8b, methoxy groups at positions 6 and 8, a 4-methoxyphenyl group at position 3a, a phenyl group at position 3 and a N,N-dimethylcarbamoyl group at position 1. Isolated from Aglaia odorata and Aglaia duperreana, it exhibits antineoplastic activity.
2-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]acetic acid
C25H28ClNO8 (505.15033580000005)
Ala Asp Asp Trp
C22H27N5O9 (505.1808692000001)
Ala Asp Trp Asp
C22H27N5O9 (505.1808692000001)
Ala Trp Asp Asp
C22H27N5O9 (505.1808692000001)
Cys Asn Asn Arg
Cys Asn Arg Asn
Cys Pro Thr Trp
C23H31N5O6S (505.19949460000004)
Cys Pro Trp Thr
C23H31N5O6S (505.19949460000004)
Cys Gln Gln Gln
Cys Arg Asn Asn
Cys Thr Pro Trp
C23H31N5O6S (505.19949460000004)
Cys Thr Trp Pro
C23H31N5O6S (505.19949460000004)
Cys Trp Pro Thr
C23H31N5O6S (505.19949460000004)
Cys Trp Thr Pro
C23H31N5O6S (505.19949460000004)
Asp Ala Asp Trp
C22H27N5O9 (505.1808692000001)
Asp Ala Trp Asp
C22H27N5O9 (505.1808692000001)
Asp Asp Ala Trp
C22H27N5O9 (505.1808692000001)
Asp Asp Glu Lys
Asp Asp Glu Gln
Asp Asp Lys Glu
Asp Asp Gln Glu
Asp Asp Trp Ala
C22H27N5O9 (505.1808692000001)
Asp Glu Asp Lys
Asp Glu Asp Gln
Asp Glu Glu Asn
Asp Glu Gly Trp
C22H27N5O9 (505.1808692000001)
Asp Glu Lys Asp
Asp Glu Asn Glu
Asp Glu Gln Asp
Asp Glu Trp Gly
C22H27N5O9 (505.1808692000001)
Asp Gly Glu Trp
C22H27N5O9 (505.1808692000001)
Asp Gly Trp Glu
C22H27N5O9 (505.1808692000001)
Asp Lys Asp Glu
Asp Lys Glu Asp
Asp Asn Glu Glu
Asp Gln Asp Glu
Asp Gln Glu Asp
Asp Trp Ala Asp
C22H27N5O9 (505.1808692000001)
Asp Trp Asp Ala
C22H27N5O9 (505.1808692000001)
Asp Trp Glu Gly
C22H27N5O9 (505.1808692000001)
Asp Trp Gly Glu
C22H27N5O9 (505.1808692000001)
Glu Asp Asp Lys
Glu Asp Asp Gln
Glu Asp Glu Asn
Glu Asp Gly Trp
C22H27N5O9 (505.1808692000001)
Glu Asp Lys Asp
Glu Asp Asn Glu
Glu Asp Trp Gly
C22H27N5O9 (505.1808692000001)
Glu Glu Asp Asn
Glu Glu Asn Asp
Glu Glu Gln Thr
Glu Glu Thr Gln
Glu Gly Asp Trp
C22H27N5O9 (505.1808692000001)
Glu Gly Trp Asp
C22H27N5O9 (505.1808692000001)
Glu Lys Asp Asp
Glu Asn Asp Glu
Glu Asn Glu Asp
Glu Gln Asp Asp
Glu Gln Glu Thr
Glu Gln Thr Glu
Glu Thr Glu Gln
Glu Thr Gln Glu
Glu Trp Asp Gly
C22H27N5O9 (505.1808692000001)
Glu Trp Gly Asp
C22H27N5O9 (505.1808692000001)
Gly Asp Glu Trp
C22H27N5O9 (505.1808692000001)
Gly Asp Trp Glu
C22H27N5O9 (505.1808692000001)
Gly Glu Asp Trp
C22H27N5O9 (505.1808692000001)
Gly Glu Trp Asp
C22H27N5O9 (505.1808692000001)
Gly Trp Asp Glu
C22H27N5O9 (505.1808692000001)
Gly Trp Glu Asp
C22H27N5O9 (505.1808692000001)
Lys Asp Asp Glu
Lys Asp Glu Asp
Lys Glu Asp Asp
Met Met Pro Gln
C20H35N5O6S2 (505.20286500000003)
Met Met Gln Pro
C20H35N5O6S2 (505.20286500000003)
Met Asn Asn Gln
Met Asn Gln Asn
Met Pro Met Gln
C20H35N5O6S2 (505.20286500000003)
Met Pro Gln Met
C20H35N5O6S2 (505.20286500000003)
Met Gln Met Pro
C20H35N5O6S2 (505.20286500000003)
Met Gln Asn Asn
Met Gln Pro Met
C20H35N5O6S2 (505.20286500000003)
Asn Cys Asn Arg
Asn Cys Arg Asn
Asn Asp Glu Glu
Asn Glu Asp Glu
Asn Glu Glu Asp
Asn Met Asn Gln
Asn Met Gln Asn
Asn Asn Cys Arg
Asn Asn Met Gln
Asn Asn Gln Met
Asn Asn Arg Cys
Asn Gln Met Asn
Asn Gln Asn Met
Asn Arg Cys Asn
Asn Arg Asn Cys
Pro Cys Thr Trp
C23H31N5O6S (505.19949460000004)
Pro Cys Trp Thr
C23H31N5O6S (505.19949460000004)
Pro Met Met Gln
C20H35N5O6S2 (505.20286500000003)
Pro Met Gln Met
C20H35N5O6S2 (505.20286500000003)
Pro Gln Met Met
C20H35N5O6S2 (505.20286500000003)
Pro Thr Cys Trp
C23H31N5O6S (505.19949460000004)
Pro Thr Trp Cys
C23H31N5O6S (505.19949460000004)
Pro Trp Cys Thr
C23H31N5O6S (505.19949460000004)
Pro Trp Thr Cys
C23H31N5O6S (505.19949460000004)
Gln Cys Gln Gln
Gln Asp Asp Glu
Gln Asp Glu Asp
Gln Glu Asp Asp
Gln Glu Glu Thr
Gln Glu Thr Glu
Gln Met Met Pro
C20H35N5O6S2 (505.20286500000003)
Gln Met Asn Asn
Gln Met Pro Met
C20H35N5O6S2 (505.20286500000003)
Gln Asn Met Asn
Gln Asn Asn Met
Gln Pro Met Met
C20H35N5O6S2 (505.20286500000003)
Gln Gln Cys Gln
Gln Gln Gln Cys
Gln Thr Glu Glu
Arg Cys Asn Asn
Arg Asn Cys Asn
Arg Asn Asn Cys
Thr Cys Pro Trp
C23H31N5O6S (505.19949460000004)
Thr Cys Trp Pro
C23H31N5O6S (505.19949460000004)
Thr Glu Glu Gln
Thr Glu Gln Glu
Thr Pro Cys Trp
C23H31N5O6S (505.19949460000004)
Thr Pro Trp Cys
C23H31N5O6S (505.19949460000004)
Thr Gln Glu Glu
Thr Trp Cys Pro
C23H31N5O6S (505.19949460000004)
Thr Trp Pro Cys
C23H31N5O6S (505.19949460000004)
Trp Ala Asp Asp
C22H27N5O9 (505.1808692000001)
Trp Cys Pro Thr
C23H31N5O6S (505.19949460000004)
Trp Cys Thr Pro
C23H31N5O6S (505.19949460000004)
Trp Asp Ala Asp
C22H27N5O9 (505.1808692000001)
Trp Asp Asp Ala
C22H27N5O9 (505.1808692000001)
Trp Asp Glu Gly
C22H27N5O9 (505.1808692000001)
Trp Asp Gly Glu
C22H27N5O9 (505.1808692000001)
Trp Glu Asp Gly
C22H27N5O9 (505.1808692000001)
Trp Glu Gly Asp
C22H27N5O9 (505.1808692000001)
Trp Gly Asp Glu
C22H27N5O9 (505.1808692000001)
Trp Gly Glu Asp
C22H27N5O9 (505.1808692000001)
Trp Pro Cys Thr
C23H31N5O6S (505.19949460000004)
Trp Pro Thr Cys
C23H31N5O6S (505.19949460000004)
Trp Thr Cys Pro
C23H31N5O6S (505.19949460000004)
Trp Thr Pro Cys
C23H31N5O6S (505.19949460000004)
4-[[5-(acetylamino)-1-methyl-1H-indol-3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]-Benzamide
C27H27N3O5S (505.1671332000001)
2,2-[[3-acetamido-4-[(2-chloro-4-nitrophenyl)azo]phenyl]imino]diethyl diacetate
TERT-BUTYL ((S)-1-((S)-2-CARBAMOYLPYRROLIDIN-1-YL)-1-OXO-3-(1-TOSYL-1H-IMIDAZOL-4-YL)PROPAN-2-YL)CARBAMATE
C23H31N5O6S (505.19949460000004)
4-Methoxyphenyl 3-O-Benzyl-2-deoxy-2-phthalimido-beta-D-glucopyranoside
C28H27NO8 (505.17365820000003)
9H-Carbazole, 9-[1,1-biphenyl]-4-yl-3-(4-chlorophenyl)-6-phenyl-
C36H24ClN (505.15971740000003)
7-[(3S,5S)-3-amino-5-methylpiperidin-1-yl]-1-cyclopropyl-8-methoxy-4-oxoquinoline-3-carboxylic acid,2-hydroxybutanedioic acid
(S)-2-[[3,5-Bis(trifluoromethyl)phenyl]thioureido]-N-benzyl-N,3,3-trimethylbutanamide
C23H25F6N3OS (505.16224320000003)
Nefazodone hydrochloride
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Nefazodone hydrochloride (BMY-13754) is a potent and selective 5HT2A (Ki=5.8 nM) antagonist with moderate inhibition of 5-HT and noradrenaline uptake (IC50 of 290 and 300 nM, respectively). Nefazodone hydrochloride is a phenylpiperazine antidepressant with less alpha-adrenergic blocking activity[1][2].
4-(FMOC-2-AMINOETHYL)-6-DIBENZOFURANPROPIONIC ACID
C32H27NO5 (505.18891320000006)
Dasatinib hydrate
C22H28ClN7O3S (505.1662768000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
4-Methylumbelliferyl2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside
C24H27NO11 (505.15840320000007)
4-Methylumbelliferyl 2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-β-D-Galactopyranoside
C24H27NO11 (505.15840320000007)
Adavivint
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor D000893 - Anti-Inflammatory Agents
peonidin 3-O-(6-O-acetyl-beta-D-glucoside)
An anthocyanin cation that is peonidin substituted at position 3 by a 6-O-acetyl-beta-D-glucosyl residue.
5-chloro-2-propyl-3-[4-[4-[2-(2H-tetrazol-5-ylmethyl)phenyl]phenyl]phenyl]imidazo[4,5-b]pyridine
N-[4-[[2-methoxy-5-[4-oxo-3-(phenylmethyl)-2-quinazolinyl]phenyl]methoxy]phenyl]acetamide
C31H27N3O4 (505.20014620000006)
(11S,12aR,13aR)-12-ethenyl-11-(beta-D-glucopyranosyloxy)-2-hydroxy-3-methoxy-5,6,12,12a,13,13a-hexahydro-11H-pyrano[4,3:4,5]pyrido[2,1-a]isoquinolin-8-one
C25H31NO10 (505.19478660000004)
2-[[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C23H28BrN3O5 (505.12122180000006)
2-[[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C23H28BrN3O5 (505.12122180000006)
(3S)-3-[[[(2S)-1-[(2S)-2-[[(4-amino-3-chlorophenyl)-oxomethyl]amino]-3,3-dimethyl-1-oxobutyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-cyanopropanoic acid ethyl ester
C24H32ClN5O5 (505.20918520000004)
3-(3-fluorophenyl)-1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-[(3aS,4S,9bS)-4-(hydroxymethyl)-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C28H31N3O4S (505.20351660000006)
3-[(3aS,4R,9bS)-4-(hydroxymethyl)-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C28H31N3O4S (505.20351660000006)
4-[(5-acetamido-1-methylindol-3-yl)methyl]-3-methoxy-N-(2-methylphenyl)sulonylbenzamide
C27H27N3O5S (505.1671332000001)
3-(3-fluorophenyl)-1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
3-(3-fluorophenyl)-1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
3-[(3aR,4S,9bR)-4-(hydroxymethyl)-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C28H31N3O4S (505.20351660000006)
[(1S)-2-[(2,5-difluorophenyl)methyl]-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C25H29F2N3O4S (505.1846738000001)
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
3-[(3aR,4R,9bR)-4-(hydroxymethyl)-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C28H31N3O4S (505.20351660000006)
[(1R)-2-[(2,5-difluorophenyl)methyl]-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C25H29F2N3O4S (505.1846738000001)
(E)-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-[3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enamide
C25H31NO10 (505.19478660000004)
2-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]acetic acid
C25H28ClNO8 (505.15033580000005)
SRT 1720 (monohydrochloride)
C25H24ClN7OS (505.14514840000004)
SRT 1720 monohydrochloride is a selective and orally active activator of SIRT1 with an EC50 of 0.10 μM, and shows less potent activities on SIRT2 and SIRT3[1].
4,5-dimethoxy-2-{[(9s)-4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-yl]oxy}benzaldehyde
(1s,2r,3r,3as,8as)-3,3a-dihydroxy-8a-(3-hydroxy-4-methoxyphenyl)-4,6-dimethoxy-n-methyl-1-phenyl-1h,2h,3h,8h-cyclopenta[a]indene-2-carboximidic acid
methyl 2-{14-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-7,15-dihydroxy-4-methyl-2,10-dioxo-5,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),11,13-tetraen-6-yl}acetate
C25H31NO10 (505.19478660000004)
(2s,3s,4s,5s,6r)-2,3-dihydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-n,n-dimethyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxamide
10-(3-hydroxyphenyl)-19-azahexacyclo[20.2.2.1⁸,¹⁹.0²,⁷.0¹⁰,¹⁸.0¹¹,¹⁶]heptacosa-1(25),2,4,6,8(27),11,13,15,22(26),23-decaene-5,12,14,24-tetrol
C32H27NO5 (505.18891320000006)
methyl 2-[(4r,6r,7s)-14-[(2r,4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-7,15-dihydroxy-4-methyl-2,10-dioxo-5,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),11,13-tetraen-6-yl]acetate
C25H31NO10 (505.19478660000004)
(3r,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2r,3r,4s,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(3s,4r,4as,5ar)-4-ethenyl-8-hydroxy-7-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(10s,18s)-10-(3-hydroxyphenyl)-19-azahexacyclo[20.2.2.1⁸,¹⁹.0²,⁷.0¹⁰,¹⁸.0¹¹,¹⁶]heptacosa-1(25),2,4,6,8(27),11,13,15,22(26),23-decaene-5,12,14,24-tetrol
C32H27NO5 (505.18891320000006)
4,5-dimethoxy-2-{[(9r)-4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-yl]oxy}benzaldehyde
(3s,4r,4as,5ar)-4-ethenyl-6-hydroxy-7-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
n-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enimidic acid
C25H31NO10 (505.19478660000004)
3,5,24,28-tetrahydroxy-21-methoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20(25),27-nonaen-26-one
(2e,4e)-n-[(3s,6s,7r,9s,10s)-7,9-dichloro-6,10-dihydroxy-2-methoxy-8-oxo-1-oxaspiro[4.5]decan-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2s)-2-amino-3-(4-hydroxyphenyl)propanoate
(4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(3s,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(2e)-n-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enimidic acid
C25H31NO10 (505.19478660000004)
(3s,4r,4as,5as)-4-ethenyl-8-hydroxy-7-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
1-[(2r,3r,4s,5r)-5-({[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}(carboxy)methyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid
methyl 5-ethyl-4-(2-oxo-2-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy}ethyl)pyridine-3-carboxylate
C25H31NO10 (505.19478660000004)
methyl 5-ethyl-4-[2-oxo-2-({3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl}methoxy)ethyl]pyridine-3-carboxylate
C25H31NO10 (505.19478660000004)
3-{[(2s,3r,4r,5r,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1λ⁴-chromen-1-ylium
(3s,4s,4as,5ar)-4-ethenyl-6-hydroxy-7-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(3s,4s,4as,5as)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
3,3a-dihydroxy-8a-(3-hydroxy-4-methoxyphenyl)-4,6-dimethoxy-n-methyl-1-phenyl-1h,2h,3h,8h-cyclopenta[a]indene-2-carboximidic acid
3-{[(3r,4s,5r,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1λ⁴-chromen-1-ylium
(3s,4s,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
4-ethenyl-7-hydroxy-8-methoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
4-ethenyl-8-hydroxy-7-methoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
3-{[(2s,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1λ⁴-chromen-1-ylium
(13r,21r,24s)-3,5,24,28-tetrahydroxy-21-methoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20(25),27-nonaen-26-one
2,3-dihydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-n,n-dimethyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxamide
2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 2-amino-3-(4-hydroxyphenyl)propanoate
4-ethenyl-7-hydroxy-8-methoxy-3-{[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)